IMMUNOHISTOCHEMISTRY UROPLAKIN-III Test
Test Cost: AED 500.0
Components:
- Test Name: IMMUNOHISTOCHEMISTRY UROPLAKIN-III Test
- Price: 500.0 AED
- Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
- Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
- Method: Immunohistochemistry
- Test Type: Cancer
- Doctor: Oncologist, Pathologist
- Test Department:
Pre Test Information:
Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details:
The immunohistochemistry Uroplakin-III test is a diagnostic test used to detect the presence of Uroplakin-III protein in tissue samples. Uroplakin-III is a specific marker for urothelial carcinoma, a type of cancer that affects the lining of the urinary tract.
During the test, a tissue sample, usually obtained through a biopsy or surgical resection, is fixed and embedded in paraffin. Thin sections of the tissue are then placed on glass slides and treated with specific antibodies that bind to Uroplakin-III protein. These antibodies are usually labeled with a fluorescent dye or an enzyme that produces a colored reaction.
If Uroplakin-III protein is present in the tissue sample, the antibodies will bind to it, and a positive signal will be observed under a microscope. This indicates the presence of urothelial carcinoma cells.
The immunohistochemistry Uroplakin-III test is commonly used in combination with other diagnostic tests, such as imaging studies and urine cytology, to confirm the diagnosis of urothelial carcinoma. It helps in determining the extent of the disease, guiding treatment decisions, and monitoring the response to therapy.
It is important to note that the immunohistochemistry Uroplakin-III test is not a standalone diagnostic tool and should be interpreted in conjunction with other clinical and pathological findings. A pathologist, a specialized doctor who examines tissue samples under a microscope, is responsible for interpreting the results of this test.
| Test Name | IMMUNOHISTOCHEMISTRY UROPLAKIN-III Test |
|---|---|
| Components | |
| Price | 500.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details | The immunohistochemistry Uroplakin-III test is a diagnostic test used to detect the presence of Uroplakin-III protein in tissue samples. Uroplakin-III is a specific marker for urothelial carcinoma, a type of cancer that affects the lining of the urinary tract. During the test, a tissue sample, usually obtained through a biopsy or surgical resection, is fixed and embedded in paraffin. Thin sections of the tissue are then placed on glass slides and treated with specific antibodies that bind to Uroplakin-III protein. These antibodies are usually labeled with a fluorescent dye or an enzyme that produces a colored reaction. If Uroplakin-III protein is present in the tissue sample, the antibodies will bind to it, and a positive signal will be observed under a microscope. This indicates the presence of urothelial carcinoma cells. The immunohistochemistry Uroplakin-III test is commonly used in combination with other diagnostic tests, such as imaging studies and urine cytology, to confirm the diagnosis of urothelial carcinoma. It helps in determining the extent of the disease, guiding treatment decisions, and monitoring the response to therapy. It is important to note that the immunohistochemistry Uroplakin-III test is not a standalone diagnostic tool and should be interpreted in conjunction with other clinical and pathological findings. A pathologist, a specialized doctor who examines tissue samples under a microscope, is responsible for interpreting the results of this test. |
